Philippe Marliere

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique, Rhodia Chimie. Active years: 1995-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philippe Marliere. Retrieved from https://idiyas.com/inventor/philippe-marliere-fwsupjf5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 23.1

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 73(Granted Patents)

Location History:

Erioves, FR (2005)
Paris, FR (1995 - 2011)
Etiolles, FR (2004 - 2011)

Company Filing History:

Centre National De La Recherche Scientifique

Evologic S.a., Marliere Technologies Societe Civile

National Institute for Agricultural Research

patents

8. 1 out of 1,853

National Institute of Health and Medical Research

patents

9. 1 out of 1,208

Scripps Research Institute

patents

10. 4 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2011

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7960103 - Method for obtaining new life forms (2011-06-14),

2. 7892838 - Method for the in vivo modification of the synthesis activity of a metabolite by means of the modification of a gene the activity of which is not the original activity (2011-02-22),

3. 7858775 - Production of 2'-deoxynucleosides and 2′-deoxynucleoside precursors from 2-dehydro-3-deoxy-D-gluconate (2010-12-28),

4. 7736899 - Cells and method for producing proteins comprising an unconventional amino acid (2010-06-15),

5. 7547513 - Mutants of deoxycytidine kinase having extended enzymatic activity (2009-06-16),

6. 7524646 - Method for diversifying the chemical composition of proteins produced in vivo by genetically disabling the editing function of their aminoacyl tRNA synthetases (2009-04-28),

7. 7425530 - Stereoselective preparation of cyclic L-amino acids (2008-09-16),

8. 7399611 - Descendants of bacteria devoid of N terminal formylation useful for the production of proteins and peptides (2008-07-15),

9. 7381555 - [object Object] (2008-06-03),

10. 7319148 - Combinatorial production of nucleotide and nucleoside (XiTP) analogues (2008-01-15),

11. 6962807 - Descendants of bacteria devoid of N terminal formylation useful for the production of proteins and peptides (2005-11-08),

12. 6686194 - Method and device for selecting accelerated proliferation of living cells in suspension (2004-02-03),

13. 5407797 - Oligonucleotide probes and methods for detecting by hybridization the (1995-04-18),

Title: The Career Journey of Inventor Philippe Marliere

Introduction

Philippe Marliere is a noteworthy figure in the field of science and innovation, based in France. Although he holds no patents to his name, his contributions through various companies highlight his dedication to research and development.

Latest Patents

Philippe Marliere does not currently have any patents registered. Despite this, his work in biotechnology has significantly influenced the industry, showcasing his inventive spirit through various projects rather than formal patent applications.

Career Highlights

Throughout his career, Philippe has worked with prominent organizations, including Scientist of Fortune, S.A. and Global Bioenergies. His experience in these companies reflects his commitment to advancing technology and finding innovative solutions in the bioenergy sector.

Collaborations

Working alongside experts in his field, Philippe has collaborated with various professionals and researchers to push the boundaries of current scientific understanding. His associations with influential companies have allowed him to contribute to significant advancements in biotechnology.

Conclusion

Philippe Marliere represents the essence of dedication in the world of innovation. While he may not hold patents, his career highlights the vital contributions of scientists in shaping the future of technology and sustainable energy solutions.

Profile summary based on public USPTO records.